UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012788
Receipt number R000014933
Scientific Title A Phase I Study of Weekly Nab-Paclitaxel/Carboplatin in Chemotherapy-Naive Patients with Advanced Non-Small-Cell Lung Cancer
Date of disclosure of the study information 2014/01/14
Last modified on 2015/05/26 14:24:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Phase I Study of Weekly Nab-Paclitaxel/Carboplatin
in Chemotherapy-Naive Patients with
Advanced Non-Small-Cell Lung Cancer

Acronym

A Phase I Study of Weekly Nab-Paclitaxel/Carboplatin
in Chemotherapy-Naive Patients with
Advanced Non-Small-Cell Lung Cancer

Scientific Title

A Phase I Study of Weekly Nab-Paclitaxel/Carboplatin
in Chemotherapy-Naive Patients with
Advanced Non-Small-Cell Lung Cancer

Scientific Title:Acronym

A Phase I Study of Weekly Nab-Paclitaxel/Carboplatin
in Chemotherapy-Naive Patients with
Advanced Non-Small-Cell Lung Cancer

Region

Japan


Condition

Condition

previously untreated advanced non-small cell lung cancer

Classification by specialty

Pneumology Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the recommended dose of chemotherapy with carboplatin plus weekly nab-paclitaxel in patients with previously untreated advanced non-small cell lung cancer

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

determine the recommended dose

Key secondary outcomes

Safety, Efficacy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

nab-paclitaxel weekly for 3 of 4 weeks (3-weekly) with carboplatin on day 1 of each 4-week cycle

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Cytologically or histologically documented non-small cell carcinoma of the lung.
2)previously untreated recurrence with distant metastasis after surgery, or previously untreated clinical stage IV or IIIB (including only patients with no indications for curative radiotherapy)
3) age older thean 20years at the time of registration
4) Have Eastern Cooperative Oncology Group performance status (PS) of 0 or 1
5) Have measurable lesions (RECIST version1.1)
6) Have adequate organ function within 14 days before study entry
leucocytes >3000/mm3
neutrophils>1,500/mm3
platelets >100,000/mm3
hemoglobin > 9g/dl],
adequate hepatic function
adequate renal function
partial pressure of arterial oxygen>60Torr or Peripheral capillary oxygen saturation>90%
8) Have signed an informed consent document

Key exclusion criteria

1)History of radiotherapy for a primary lesion
2)Superior vena cava syndrome
3)Hisstory of severe drug allergy
4)With massive or uncontrolled pleural effusion
5)With massive or uncontrolled pericardial effusionor ascites
6)With active infection
7)interstitial pneumoia/active lung fibrosis on chest x-ray
8)With symptomatic brain metastasis
9)active concomitant malignancy
10)Uncontrolled psychiatric disease
11)Peripheral sensory or motor neuropathy severe than Grade 2(by CTCAE ver4.0)
12)Others judged by attending physician

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masataka Hirabayashi

Organization

Hyogo Prefectural Amagasaki Hospital

Division name

Department of Respiratory Medicine

Zip code


Address

1-1-1, Higashidaimotsucho, Amagasaki-shi, Hyogo, 660-0828, Japan

TEL

06-6482-1521

Email

Masataka_Hirabayashi@pref.hyogo.lg.jp


Public contact

Name of contact person

1st name
Middle name
Last name Katsuya Hirano

Organization

Hyogo Prefectural Amagasaki Hospital

Division name

Department of Respiratory Medicine

Zip code


Address

1-1-1, Higashidaimotsucho, Amagasaki-shi, Hyogo, 660-0828, Japan

TEL

06-6482-1521

Homepage URL


Email

khirano1979@gmail.com


Sponsor or person

Institute

Department of Respiratory Medicine in Hyogo Prefectural Amagasaki Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫県立尼崎病院


Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 14 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2013 Year 12 Month 13 Day

Date of IRB


Anticipated trial start date

2014 Year 01 Month 14 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 01 Month 08 Day

Last modified on

2015 Year 05 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014933


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name